Pro Medicus (ASX:PME) Insider Peter Kempen Acquires 600 Shares of Stock

Pro Medicus Limited (ASX:PME) insider Peter Kempen acquired 600 shares of the stock in a transaction that occurred on Monday, December 29th. The stock was acquired at an average cost of A$224.00 per share, for a total transaction of A$134,400.00.

Pro Medicus Stock Performance

The company has a market cap of $29.16 billion, a PE ratio of 351.99, a PEG ratio of 3.87 and a beta of 0.56. The company has a debt-to-equity ratio of 1.10, a current ratio of 5.98 and a quick ratio of 4.39.

Pro Medicus Company Profile

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products.